HealthDay on MSN
CHEST: Mortality Down With GLP-1 Receptor Agonist Use in T2D, Especially in Those With OSA
Cosmo Fowler, M.D., from Emory University in Atlanta, and colleagues examined data from the TriNetX U.S. Collaborative Network to examine whether OSA modifies outcomes in patients with T2DM receiving ...
GLP-RAs significantly improved liver histology, liver fat, and metabolic markers in patients with MASLD, outperforming DDP-4 inhibitors but increasing mild GI side effects.
Studies combing through past patient data have made a similar link between drugs like Ozempic and a loss of appetite for more than just food.
13hon MSN
Weight loss injections vs. Weight loss surgery: Study finds surgery takes the lead over injections
Weight loss surgery offers lasting results that go beyond reducing body weight. It helps improve diabetes control, supports ...
GLP-1 weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, ...
Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study ...
Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...
Adults who are smokers are less likely to be prescribed a GLP-1 than nonsmokers, even though smokers are more likely to be ...
A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.
Everyday Health on MSN
Drugs Like Mounjaro and Wegovy Could Make Alcohol Less Intoxicating
A small study found that drugs like Ozempic, Wegovy, and Mounjaro change the way the body processes alcohol, making it less ...
MedPage Today on MSN
GLP-1 Drugs Tied to Lower Risk of Legal Blindness in People With Diabetes
O RLANDO -- Adding another twist to the ongoing debate about the effects of weight-loss drugs on vision, a retrospective cohort study linked GLP-1 receptor agonists to a lower risk of legal blindness ...
GLP-1s may confer greater protection from major adverse cardiovascular events compared with sulfonylureas, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results